Cyclopharm Acquires Scandinavian Distribution Business
Filed with ASX · · 2 pages · English
Earlier from Cyclopharm
- 40 Patient Milestone Achieved For Technegas USFDA Trial
- CYC CEO Presentation 2017 Australian Microcap Conference
- Technegas USFDA Clinical Trial - Patient Enrolment Underway
- Cyclopharm acquires European distribution business
- Advancing Molecular Imaging in NSW
Later from Cyclopharm
- Better Defining Airways Disease with Technegas
- CYC 2018 AGM Presentation
- Cyclopharm 2018 First Half Preliminary Headline Update
- Positive USFDA Meeting - Technegas sales expected in 2019
- CANM Endorses Technegas
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm